These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2575719

  • 1. Comparison of sensorimotor and cognitive performance of acute schizophrenic inpatients treated with remoxipride or haloperidol.
    Classen W, Laux G.
    Neuropsychobiology; 1989; 21(3):131-40. PubMed ID: 2575719
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
    Mendlewicz J, de Bleeker E, Cosyns P, Deleu G, Lotstra F, Masson A, Mertens C, Parent M, Peuskens J, Suy E.
    Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
    Andersen J, Kørner A, Ostergaard P, Fensbo C, Birket-Smith M, Thiesen S, Hansen NR, Fogh M, Kristensen M, Møller-Nielsen EM.
    Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467
    [Abstract] [Full Text] [Related]

  • 6. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
    den Boer JA, Westenberg HG.
    Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
    den Boer JA, Ravelli DP, Huisman J, Ohrvik J, Verhoeven WM, Westenberg HG.
    Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
    [Abstract] [Full Text] [Related]

  • 9. A double-blind multicentre study comparing remoxipride, two and three times daily, with haloperidol in schizophrenia.
    Laux G, Klieser E, Schröder HG, Dittmann V, Unterweger B, Schubert H, König P, Schöny HW, Bunse J, Beckmann H.
    Acta Psychiatr Scand Suppl; 1990; 358():125-9. PubMed ID: 1978471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cognitive disturbances in neuroleptic therapy.
    Strauss WH, Klieser E.
    Acta Psychiatr Scand Suppl; 1990; 358():56-7. PubMed ID: 1978491
    [Abstract] [Full Text] [Related]

  • 17. Plasma concentrations of remoxipride and haloperidol in relation to prolactin and short-term therapeutic outcome in schizophrenic patients.
    Lahdelma RL, Appelberg B, Kuoppasalmi K, Katila H, Rimón R.
    Eur Neuropsychopharmacol; 1991 Dec; 1(4):535-40. PubMed ID: 1688013
    [Abstract] [Full Text] [Related]

  • 18. A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial.
    Lapierre YD, Nair NP, Chouinard G, Awad AG, Saxena B, Jones B, McClure DJ, Bakish D, Max P, Manchanda R.
    Acta Psychiatr Scand Suppl; 1990 Dec; 358():72-7. PubMed ID: 1978496
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.